Patents by Inventor Daniel A. Geselowitz

Daniel A. Geselowitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250144046
    Abstract: The present disclosure describes novel compounds and compositions and methods of making and using thereof related that are capable of inhibiting PAK1 and associated diseases or disorders, including tumors and cancerous cells. The inventive compounds are more efficacious and stable than IPA-3 without needing liposomal formulations as vehicles for the compounds.
    Type: Application
    Filed: January 27, 2023
    Publication date: May 8, 2025
    Inventors: David CRICH, Somanath SHENOY, Brian CUMMINGS, Harvey D. HOMAN, Daniel A. GESELOWITZ
  • Patent number: 5376525
    Abstract: A method for detecting mycoplasma infection in a sample by contacting the sample with labeled oligonucleotides, then measuring incorporation (if any) of the label into mycoplasma RNA.
    Type: Grant
    Filed: September 24, 1992
    Date of Patent: December 27, 1994
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Daniel A. Geselowitz, Leonard M. Neckers, Lyn D. Olson